Annual ROE
-785.27%
-654.68%-501.32%
December 31, 2023
Summary
- As of February 7, 2025, VRPX annual return on equity is -785.27%, with the most recent change of -654.68% (-501.32%) on December 31, 2023.
- During the last 3 years, VRPX annual ROE has fallen by -888.20% (-862.92%).
- VRPX annual ROE is now -454.65% below its all-time high of 221.42%, reached on December 31, 2018.
Performance
VRPX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
1283.71%
+2838.45%+182.57%
September 30, 2024
Summary
- As of February 7, 2025, VRPX quarterly return on equity is 1283.71%, with the most recent change of +2838.45% (+182.57%) on September 30, 2024.
- Over the past year, VRPX quarterly ROE has increased by +1391.36% (+1292.48%).
- VRPX quarterly ROE is now at all-time high.
Performance
VRPX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VRPX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -501.3% | +1292.5% |
| 3 y3 years | -862.9% | +2117.5% |
| 5 y5 years | -454.6% | +2117.5% |
VRPX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2341.8% | at low | at high | +182.6% |
| 5 y | 5-year | -748.9% | at low | at high | +182.6% |
| alltime | all time | -454.6% | at low | at high | +182.6% |
Virpax Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 1283.71%(-182.6%) |
| Jun 2024 | - | -1554.74%(+349.5%) |
| Mar 2024 | - | -345.90%(+104.6%) |
| Dec 2023 | -785.27%(+501.3%) | -169.04%(+57.0%) |
| Sep 2023 | - | -107.65%(+12.0%) |
| Jun 2023 | - | -96.12%(+4.1%) |
| Mar 2023 | - | -92.33%(+1.8%) |
| Dec 2022 | -130.59% | -90.70%(+15.9%) |
| Sep 2022 | - | -78.29%(+47.6%) |
| Jun 2022 | - | -53.04%(+6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -49.78%(-0.9%) |
| Dec 2021 | -32.16%(-131.2%) | -50.21%(-21.1%) |
| Sep 2021 | - | -63.63%(-79.9%) |
| Jun 2021 | - | -316.07%(-74.0%) |
| Mar 2021 | - | -1216.39%(-1229.9%) |
| Dec 2020 | 102.93%(-14.9%) | 107.65%(-18.3%) |
| Sep 2020 | - | 131.77%(+37.1%) |
| Jun 2020 | - | 96.12%(+93.6%) |
| Mar 2020 | - | 49.65%(+93.8%) |
| Dec 2019 | 121.02%(-45.3%) | 25.62% |
| Dec 2018 | 221.42% | - |
FAQ
- What is Virpax Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual ROE year-on-year change?
- What is Virpax Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly ROE year-on-year change?
What is Virpax Pharmaceuticals annual return on equity?
The current annual ROE of VRPX is -785.27%
What is the all time high annual ROE for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual return on equity is 221.42%
What is Virpax Pharmaceuticals annual ROE year-on-year change?
Over the past year, VRPX annual return on equity has changed by -654.68% (-501.32%)
What is Virpax Pharmaceuticals quarterly return on equity?
The current quarterly ROE of VRPX is 1283.71%
What is the all time high quarterly ROE for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly return on equity is 1283.71%
What is Virpax Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, VRPX quarterly return on equity has changed by +1391.36% (+1292.48%)